This is where all download will be listed, utilizing the Page Add plugin.
File Name | S22-Policy-Stoa-31-NEG-MCED.docx |
File Size | 73.67 KB |
Date added | December 20, 2021 |
Category | Policy (Stoa) |
Author | Vance Trefethen |
Resolved: The United States federal government substantially reform the use of Artificial Intelligence technology
Case Summary: The AFF plan passes the Medicare Multi-Cancer Early Detection Screening Coverage Act, a bill pending in Congress but not yet enacted. It amends Title XVIII of the Social Security Act to allow Medicare to cover any MCED tests that are approved by the FDA. MCED is an AI-driven revolutionary technique for early detection of cancer. It can detect cells deposited in the blood that are markers for dozens of types of cancer, many of which have zero methods of early screening today. A simple blood test can catch cancer much earlier and allow treatment before it gets too bad to treat.
This NEG brief tells us “not so fast” – AFF is getting ahead of the science with all the hype. No MCED has been approved by the FDA yet, so there’s nothing for Medicare to pay for. Let’s do more study and make sure this works before we worry about paying for it. And if it does work, we’d all be better off NOT having Medicare pay for it, since Medicare has a habit of stifling innovation and driving higher prices.